Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
CAPSULE
**DOSAGE AND ADMINISTRATION:** Undesirable effects may be minimized by using the minimum effective dose for the shortest duration necessary to control symptoms. The oral dosage form of mefenamic acid may be taken with food if gastrointestinal upset occurs. Mild to moderate pain/rheumatoid arthritis/osteoarthritis in adults and adolescents over 14 years of age: 500 mg three times daily. Dysmenorrhea: 500 mg three times daily, to be administered at the onset of menstrual pain and continued while symptoms persist according to the judgment of the physician. Menorrhagia: 500 mg three times daily, starting with the onset of bleeding and associated symptoms and continued according to the judgment of the physician.
ORAL
Medical Information
**INDICATIONS AND USES:** Mefenamic acid capsules is used to relieve various types of pain such as: headache; body aches, rheumatoid arthritis, osteoarthritis; muscle and joint pains; toothache; sprains; painful menstruation (dysmenorrhea and menorrhagia); trauma-related pains.
**CONTRAINDICATIONS:** - Hypersensitivity to the active substance or any of the excipients - Inflammatory bowel disease. - History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. - Active or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding). - Severe heart failure, hepatic failure and renal failure. - History of hypersensitivity reaction to other NSAIDs. - During the last trimester of pregnancy. - Treatment of pain after coronary artery bypass graft (CABG) surgery.
M01AG01
mefenamic acid
Manufacturer Information
NAINA MOHAMED & SONS PRIVATE LIMITED
MICRO LABS LTD
Active Ingredients
Documents
Package Inserts
Mefril-250 PI.pdf
Approved: January 17, 2023